Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth J Pienta

Showing results (261-270 of 519) with videos related to

Pageof 52
Sort By:
Journal of Cellular Biochemistry|July 23, 2008
CCL2 induces prostate cancer transendothelial cell migration via activation of the small GTPase RacKenneth L van Golen, Chi Ying, Linda Sequeira, et al.
Cancer Research|July 5, 2005
Identification of leukocyte E-selectin ligands, P-selectin glycoprotein ligand-1 and E-selectin ligand-1, on human metastatic prostate tumor cellsCharles J Dimitroff, Leyla Descheny, Natalia Trujillo, et al.
Scientific Reports|January 6, 2026
Cancer cells surviving cisplatin chemotherapy increase stress-induced OMA1 activity and mitochondrial fragmentationMelvin Li, Chenille A McCullum, Louis T A Rolle, et al.
Molecular Cancer Research : MCR|October 7, 2018
AXL Is a Putative Tumor Suppressor and Dormancy Regulator in Prostate CancerHaley D Axelrod, Kenneth C Valkenburg, Sarah R Amend, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Cancer cells surviving cisplatin chemotherapy increase stress-induced OMA1 activity and mitochondrial fragmentationMelvin Li, Chenille A McCullum, Louis T A Rolle, et al.
Bone|March 23, 2011
Drugs which inhibit osteoclast function suppress tumor growth through calcium reduction in boneXin Li, Jinhui Liao, Serk In Park, et al.
Neoplasia (New York, N.Y.)|July 27, 2006
CCL2 is a potent regulator of prostate cancer cell migration and proliferationRobert D Loberg, LaShon L Day, Jason Harwood, et al.
BJU International|July 30, 2016
Risk prediction tool for grade re-classification in men with favourable-risk prostate cancer on active surveillanceMufaddal M Mamawala, Karthik Rao, Patricia Landis, et al.
Neoplasia (New York, N.Y.)|January 22, 2026
Polyploid cisplatin-resistant cancer cells have altered nuclear organization and epigenomic statusAnna Lk Gonye, Linda Orzolek, Christopher Cherry, et al.
Oncotarget|March 29, 2014
Endothelial integrin α3β1 stabilizes carbohydrate-mediated tumor/endothelial cell adhesion and induces macromolecular signaling complex formation at the endothelial cell membraneOlga V Glinskii, Feng Li, Landon S Wilson, et al.
Pageof 52

Showing results (261-270 of 519) with videos related to

Sort By:
Pageof 52
Journal of Cellular Biochemistry|July 23, 2008
CCL2 induces prostate cancer transendothelial cell migration via activation of the small GTPase RacKenneth L van Golen, Chi Ying, Linda Sequeira, et al.
Cancer Research|July 5, 2005
Identification of leukocyte E-selectin ligands, P-selectin glycoprotein ligand-1 and E-selectin ligand-1, on human metastatic prostate tumor cellsCharles J Dimitroff, Leyla Descheny, Natalia Trujillo, et al.
Scientific Reports|January 6, 2026
Cancer cells surviving cisplatin chemotherapy increase stress-induced OMA1 activity and mitochondrial fragmentationMelvin Li, Chenille A McCullum, Louis T A Rolle, et al.
Molecular Cancer Research : MCR|October 7, 2018
AXL Is a Putative Tumor Suppressor and Dormancy Regulator in Prostate CancerHaley D Axelrod, Kenneth C Valkenburg, Sarah R Amend, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Cancer cells surviving cisplatin chemotherapy increase stress-induced OMA1 activity and mitochondrial fragmentationMelvin Li, Chenille A McCullum, Louis T A Rolle, et al.
Bone|March 23, 2011
Drugs which inhibit osteoclast function suppress tumor growth through calcium reduction in boneXin Li, Jinhui Liao, Serk In Park, et al.
Neoplasia (New York, N.Y.)|July 27, 2006
CCL2 is a potent regulator of prostate cancer cell migration and proliferationRobert D Loberg, LaShon L Day, Jason Harwood, et al.
BJU International|July 30, 2016
Risk prediction tool for grade re-classification in men with favourable-risk prostate cancer on active surveillanceMufaddal M Mamawala, Karthik Rao, Patricia Landis, et al.
Neoplasia (New York, N.Y.)|January 22, 2026
Polyploid cisplatin-resistant cancer cells have altered nuclear organization and epigenomic statusAnna Lk Gonye, Linda Orzolek, Christopher Cherry, et al.
Oncotarget|March 29, 2014
Endothelial integrin α3β1 stabilizes carbohydrate-mediated tumor/endothelial cell adhesion and induces macromolecular signaling complex formation at the endothelial cell membraneOlga V Glinskii, Feng Li, Landon S Wilson, et al.
Pageof 52